Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Rethinking corticosteroid therapy in autoimmune neurology

Chiek Teoh CS. et al, (2025), Brain

Clinical phenotype and outcomes in autoimmune encephalitis after herpes simplex virus encephalitis: a systematic review and meta-analysis.

Cleaver J. et al, (2025), J Infect

Neurological examinations for psychiatric patients: A systematic review.

Phillips J. et al, (2025), Schizophr Res, 284, 32 - 40

Thymic central tolerance takes centre stage in autoimmune disease

Bunni SM-A. and Handel AE., (2025), The Lancet Regional Health - Western Pacific, 60, 101638 - 101638

Distinctive seizure signature in the first video case-control study of a naturally-occurring feline autoimmune encephalitis model.

Binks SNM. et al, (2025), Brain Behav Immun, 126, 289 - 296

Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitis.

Sun B. et al, (2025), Sci Adv, 11

Capturing what matters: Patient-reported LGI1-ANTibody encephalitis outcome RatiNg scale (LANTERN).

Kelly MJ. et al, (2025), Ann Clin Transl Neurol

Permissive central tolerance plus defective peripheral checkpoints licence pathogenic memory B cells in CASPR2-antibody encephalitis.

Sun B. et al, (2025)

Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.

Blanco E. et al, (2025), J Exp Med, 222

Can liaison neurology add value to patient care within a mental health setting?

Ward JH. et al, (2025), Br J Psychiatry, 226, 47 - 48

Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review.

Harris SL. et al, (2025), BMJ Neurol Open, 7

Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in CASPR2-antibody disease

Ceronie B. et al, (2024), Annals of Neurology

A systematic review of clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy

Harris SL. et al, (2024)

The immunology underlying CNS autoantibody diseases.

Cleaver J. et al, (2024), Rev Neurol (Paris), 180, 916 - 930

Permissive Central Tolerance Plus Defective Peripheral Checkpoints License Pathogenic Memory B cells in CASPR2-Antibody Encephalitis

Harrison A. et al, (2024), Neurology, 103

Oculomotor Nerve Neuromyotonia: An Inflammatory Syndrome.

Handel A. et al, (2024), Neurology, 103

LGI1-antibody encephalitis: how to approach this highly treatable dementia mimic in memory and mental health services.

Binks SNM. et al, (2024), Br J Psychiatry, 224, 252 - 257

Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.

Kelly MJ. et al, (2024), JAMA Neurol, 81, 525 - 533

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis.

Binks SNM. et al, (2024), Ann Clin Transl Neurol, 11, 1053 - 1058

MOG-IgA as a Potential Marker of Germinal Center Activity.

Handel AE. et al, (2024), JAMA Neurol, 81

Load More

Include forthcoming?